G. Ornati

In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients.

Jürgen Geisler, Nicholas King, Gun Anker et al. · PubMed · 1998 · 316 citations

Bolus Injection, Breast Oncology, Gynecology +17

Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I study.

Dag Clement Johannessen, Terje Engan, E. Di Salle et al. · PubMed · 1997 · 193 citations

Breast Oncology, Gynecology, Pharmacotherapy +18

Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in postmenopausal women.

T.R. Jeffry Evans, E. Di Salle, G. Ornati et al. · PubMed · 1992 · 150 citations

Gynecology, Pharmacotherapy, Reproductive Endocrinology +18

6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): A new irreversible aromatase inhibitor

D. Giudici, G. Ornati, G. Briatico et al. · Journal of Steroid Biochemistry · 1988 · 148 citations

Medicinal Chemistry, Biochemistry, Natural Sciences +8

Antiestrogenic and antitumor properties of the new triphenylethylene derivative toremifene in the rat

E. Di Salle, T. Zaccheo, G. Ornati · Journal of Steroid Biochemistry · 1990 · 69 citations

Medicinal Chemistry, Antitumor Properties, Derivatives +4